In Brief
Resolution of the inflammatory response to infections is important to prevent damage to the host. Dalli et al. find that the vagus nerve promotes bacterial clearance by regulating tissue ILC3 numbers and upregulating the protective mediator PCTR1, which conditions peritoneal macrophage responses and promotes resolution of infection.
SUMMARY
Uncovering mechanisms that control immune responses in the resolution of bacterial infections is critical for the development of new therapeutic strategies that resolve infectious inflammation without unwanted side effects. We found that disruption of the vagal system in mice delayed resolution of Escherichia coli infection. Dissection of the right vagus decreased peritoneal group 3 innate lymphoid cell (ILC3) numbers and altered peritoneal macrophage responses. Vagotomy resulted in an inflammatory peritoneal lipid mediator profile characterized by reduced concentrations of pro-resolving mediators, including the protective immunoresolvent PCTR1, along with elevated inflammation-initiating eicosanoids. We found that acetylcholine upregulated the PCTR biosynthetic pathway in ILC3s. Administration of PCTR1 or ILC3s to vagotomized mice restored tissue resolution tone and host responses to E. coli infections. Together these findings elucidate a host protective mechanism mediated by ILC3-derived pro-resolving circuit, including PCTR1, that is controlled by local neuronal output to regulate tissue resolution tone and myeloid cell responses.
INTRODUCTION
Progression of the acute inflammatory response is highly coordinated, and when self-limited, leads to disposal of the inciting stimulus and re-establishment of function in affected organ(s) (Chiang et al., 2012; Fullerton et al., 2014; Leslie, 2015; Nathan, 2012; Serhan et al., 2015; Tabas and Glass, 2013; Ward, 2012) . The initiation of this vital response is governed by diverse local signals that include cytokines, chemokines (Dinarello, 2011) , and chemical mediators produced via stereospecific conversion of precursor essential fatty acids (Nakamura and Shimizu, 2011; Proia and Hla, 2015; Samuelsson, 2012; Serhan et al., 2015) . These mediators form gradients that promote leukocyte recruitment to the site of injury and/or infection (Haeggströ m and Funk, 2011; Samuelsson, 2012) . Termination or resolution of this host response is now appreciated to be an active process (Chiang et al., 2012; Leslie, 2015; Serhan et al., 2015) orchestrated by specific signals including gases (Flannigan et al., 2014) , proteins (Leoni et al., 2015) , and novel essential fatty acid-derived mediators (Leslie, 2015; Serhan et al., 2015; Tabas and Glass, 2013) .
The first of the resolution-phase lipid mediators described are now grouped in four new families of chemical mediators termed specialized pro-resolving mediators (SPMs) that include resolvins, protectins, lipoxins, and maresins (Serhan et al., 2015) . SPMs are each proven agonists in the host immune system regulating both innate (Campbell et al., 2010; Chiang et al., 2012) and adaptive (Gao et al., 2015) immunity. These mediators display potent actions controlling phagocyte clearance of bacterial infections and reduce collateral tissue injury and inflammation. Consequently, dysregulated production of these pro-resolving mediators is associated with disease onset and/or severity (Chiang et al., 2012; Dalli et al., 2015b) . Given the alarming increase in bacterial multidrug resistance, there is an urgent need for the development of novel strategies to clear invading bacteria without compromising the host, as immune suppression is a major side effect of many current therapeutics (Chiang et al., 2012; Nathan, 2012; Ward, 2012) . Thus, understanding the endogenous mechanisms that regulate SPM production in infections can provide insights into potential novel therapeutic approaches for combating infections that may limit unwanted side effects.
The neuronal reflex senses peripheral inflammation and coordinates the host response to injury and/or infection, regulating events within the initiation of inflammation (Pavlov and Tracey, 2012; Rosas-Ballina et al., 2011) . Recently, we found that during acute sterile inflammation the vagal system regulates docosahexaenoic acid (DHA)-derived pro-resolving mediators resolvin (Rv)D1, RvD3, and protectin D1 (Mirakaj et al., 2014) . In this context, the role of the neural reflex in regulating resolution status of peripheral tissues as well as the role(s) of this reflex in promoting the resolution of infectious inflammation remains of interest. Thus it is critical to gain insights into these processes since they may facilitate development of host-directed resolution-based therapeutics to help combat infections (Lee and Zeldin, 2015) . For this purpose, we investigated the impact of vagotomy on regulating the resolution mechanisms in the peritoneum as well as how this influenced innate immune responses during self-resolving Escherichia coli infections. Results from these experiments indicated that vagal disruption led to dysregulation of tissue retinoic acid-related orphan receptor g t (RORgt) + CD335 + group 3 innate lymphoid cell (ILC3) numbers, resting peritoneal lipid mediator profiles, and macrophage responses. This in turn was associated with delayed resolution of infectious inflammation. Together, the present findings identify ILC3s and PCTR1 as central mediators in neuronal control of host response to peritoneal infections.
RESULTS

Vagotomy Alters Resting Peritoneal Lipid Mediator Profiles
Events occurring during the early phases of inflammation may have a profound impact on the amplitude and duration of these responses (Dalli et al., 2015a) . SPMs orchestrate the host response to both sterile and infectious insults (Chiang et al., 2012; Dalli et al., 2015a) . To establish the role of the vagus system in regulating the tissue pro-resolution tone, we assessed peritoneal lipid mediator (LM) profiles prior to infectious challenge in mice subjected to resection of the right vagus trunk and control (sham) mice. Using liquid chromatography tandem mass spectrometry (LC-MS-MS)-based LM metabololipidomics, we identified mediators from all three major bioactive metabolomes in peritoneal lavages (Figures 1A and 1B) . These included the resolvins, protectins, and maresins from docosahexaenoic acid, E-series resolvins and the arachidonic acid-derived lipoxins, leukotrienes (LTs), thromboxanes (TXs), and prostaglandins (PGs). Multivariate analysis of lipid mediator profiles obtained from sham and vagotomized mice at 1, 3, and 7 days after vagotomy showed that conditions segregated into distinct clusters ( Figure 1C ). Assessment of the loading plot for these lipid mediator profiles demonstrated a strong association between the recently elucidated host-protective mediator PCTR1 (16R-glutathionyl, 17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid) (Dalli et al., 2015c) and sham mice with a variable importance in projection (VIP; see Experimental Procedures for details) score > 1. Moreover, the peritoneal PCTR1 concentration was reduced as early as 1 day after vagotomy, with the changes reaching statistical significance on days 3 and 7 when compared to peritoneal lavages from sham mice ( Figure 1C and Table 1 ). In these lavages, there were also significant increases in the concentrations of several inflammation-initiating mediators such as PGF 2a compared to lavages from sham mice. These alterations in peritoneal lipid mediator profiles were also associated with a time-dependent decrease in peritoneal acetylcholine (ACh) concentrations after vagotomy ( Figure 1D ).
Peritoneal Innate Immunity Is Dysregulated in Vagotomized Mice
We next investigated whether vagotomy also led to perturbation of the resident peritoneal leukocyte population. In peritoneal lavages from naive mice, we identified a cell population that was Figure S1 ). To further characterize this novel ILC3 population, we sorted peritoneal ILC3s using a validated gating strategy highlighted in Figure S2 that gave essentially identical cell numbers to that described in the literature (Robinette et al., 2015) and outlined in Figure S1 . We then assessed the expression of a panel of genes that are upregulated in ILC3s when compared to NK1.1 cells (Robinette et al., 2015) . Real-time PCR analysis of these sorted cells demonstrated that peritoneal ILC3s expressed higher levels of Il22, Il23r, Il1r1, Igfbp7, and Pram1 ( Figure S3 ) than NK1.1 cells. We next assessed the impact of vagotomy on these cells and found that when mice were subjected to vagotomy, there was a perturbation of this cell population with a significant reduction in the number of these cells ( Figure 2A Vagotomy also led to time-dependent alterations in the expression of macrophage phenotypic markers, including CD206 and major histocompatibility complex class II (MHCII), when compared to cells from sham mice ( Figure 2C and Table S1 ). Vagotomy also led to alterations in the lipid mediator profiles of peritoneal macrophages with a reduction in the concentrations of host protective mediators including PCTR1, PD1, and the lipoxin pathway marker 5,15-diHETE ( Figure 2D and Table S2) . Therefore these results demonstrate that disruption of the right vagus trunk leads to an alteration in the peritoneal leukocyte composition as well as macrophage phenotype.
Vagotomy of the Right Vagus Trunk Delays the Resolution of Infectious Inflammation
We next tested whether these perturbations in the tissue responses impacted the host's ability to clear bacterial infections. Inoculation of mice with 10 6 CFU E. coli resulted in a self-limited inflammatory response with maximal infiltration of Ly6G + CD11b + neutrophils (J max ) occurring at $12 hr (T max ) followed by a decline ( Figure 3A ). Neutrophil numbers reached 50% of maximum (J 50 ) at $34 hr (T 50 ), giving a resolution interval (R i ), i.e., the difference between T max and T 50 , of $22 hr. In contrast, in mice subjected to unilateral vagotomy of the right vagus, E. coli inoculation led to a significant increase (11.9 ± 0.6 3 10 6 versus 7.1 ± 0.9 3 10 6 cells/exudate; p < 0.05) in peritoneal neutrophil recruitment and delayed the resolution of inflammation with an increased R i to $32 hr ( Figure 3A ). In vagotomized mice we also found a significant reduction in E. coli phagocytosis by exudate leukocytes (p < 0.05) and increased exudate bacterial counts ( Figures 3B and 3C ).
To determine the specificity of the response elicited by the right vagus nerve in regulating peritoneal resolution tone, we next investigated peritoneal host responses after resection of the left vagus nerve. Assessment of macrophage phenotypic markers demonstrated that vagotomy of the left nerve led to a significant reduction in the expression of interleukin 10 (IL-10) and CD11b and an upregulation of cyclooxygenase (COX)-2, with the remaining macrophage markers being essentially unaltered ( Figure S4A ) when compared to macrophages from sham mice. Resection of the left vagus nerve did not lead to significant changes in peritoneal PCTR1 levels or macrophage and CD335 + ILC3 ( Figures S4B-S4D ) numbers. When challenged with E. coli, mice subjected to left vagotomy gave a maximum neutrophil infiltration (4.5 ± 0.7 3 10 6 versus 5.1 ± 0.3 310 6 neutrophils/ exudate, left vagotomy versus sham) R i (26 versus 27 hr, left vagotomy versus sham) and exudate bacterial loads (1.9 ± 0.5 3 10 6 versus 3.6 ± 1.0 3 10 6 CFU/exudate, left vagotomy versus sham) that were comparable to sham mice (Figures S4E and S4F) . Together these results demonstrate that the right vagus nerve regulates peritoneal resolution tone and immunity during infections, whereas left vagal trunk disruption did not Mice were subjected to vagotomy or sham procedure, peritoneal lavages were collected at the indicated intervals, and LM levels were assessed using LM-metabololipidomics. Results are expressed as pg/lavage; mean ± SEM; n = 3-5 mice per group. *p < 0.05 versus sham, minus sign (À) indicates below limit, limit $0.1 pg. With Q1, M-H (parent ion); and Q3, diagnostic ion in the MS-MS (daughter ion).
significantly alter innate immune responses to E. coli infections. Therefore we next sought evidence for mechanisms regulated by the right vagus nerve in regulating these host responses.
PCTR1 Rescues the Dysregulated Inflammatory Response in Vagotomized Mice
Having found that a reduction in peritoneal PCTR1 levels was associated with altered peritoneal macrophage phenotype and impaired host responses to infections and given the host protective actions of PCTR1 in infections (Dalli et al., 2015c; Ramon et al., 2016) , we tested whether administration of PCTR1 could rectify the altered peritoneal macrophage profile. Mice were administered PCTR1 (75 ng/mouse) and peritoneal lavages collected at 16 hr. Multivariate analysis of peritoneal F4/ 80 + CD11b + macrophage lineage markers demonstrated a rightward shift in the cluster representing macrophage profiles from vagotomized mice compared to sham macrophages ( Figure 4A ). Macrophages from vagotomized mice displayed higher expression of CD11b, F4/80, and T cell immunoglobulin mucin protein (TIM-4). Administration of PCTR1 to vagotomized mice resulted in increases in several of the markers downregulated by vagus disruption including inducible nitric oxide synthase (iNOS), Arginase (Arg)-1, and CD11c, resulting in a leftward shift in the macrophage lineage profile ( Figure 4A and Table S3 ). This shift in peritoneal macrophage phenotype was associated with an improved ability of peritoneal macrophages to phagocytose bacteria ( Figure 4B ) and a reduction in several pro-inflammatory molecules including C-X-C motif ligand (CXCL)1 and the mouse homolog of interleukin 8 (KC) (n = 3 mice per group; p < 0.05). In addition, PCTR1 administration also led to a shift in the peritoneal lipid mediator profile ( Figure 4C and Table S4 ). Here we found a rightward shift in the LM cluster from vagotomized mice compared to sham mice. Administration of PCTR1 to vagotomized mice reversed this shift in peritoneal lipid mediator profiles after vagotomy with the resulting lipid mediator profile cluster giving similar co-ordinates as those obtained with sham mice. This leftward shift in the LM profile clusters was accompanied by an upregulation of several SPMs known to be organ protective (Serhan et al., 2015) including AT-LXA 4 (15R-LXA 4 ), RvD3, and PCTR3 and a downregulation of inflammation initiation Tables S1 and S2. eicosanoids (Haeggströ m and Funk, 2011; Samuelsson, 2012) such as PGD 2 , PGF 2a , and LTB 4 ( Figure 4C and Table S4 ). Since PCTR1 administration rectified peritoneal macrophage responses as well as the peritoneal lipid mediator profile in vagotomized mice, we next tested whether this was sufficient to restore the host response during infections. PCTR1 given to vagotomized mice 16 hr prior to E. coli inoculation rescued the host response, significantly reduced neutrophil recruitment, and shortened the resolution interval from $36 hr to 22 hr. In comparison, the resolution interval was shortened to 16 hr when PCTR1 was administered to sham mice (Figure 4D ). In addition, PCTR1 administration significantly upregulated E. coli phagocytosis by exudate leukocytes, reduced exudate bacterial loads, and upregulated macrophage efferocytosis, key responses in the resolution of inflammation (Fullerton et al., 2014; Serhan et al., 2015) , in both vagotomized and sham mice (Figures 4E-4G) . Together these results demonstrate that PCTR1 rectifies peritoneal macrophage phenotype and host responses to E. coli infections in vagotomized mice.
ILC3s Regulate Peritoneal Macrophage Production of PCTR1 and Accelerate Resolution of Infectious Inflammation
In vagotomized mice we found significant decreases in peritoneal ACh concentrations as well as in the production of PCTR1 by peritoneal macrophages (Figures 1 and 2) . Given the role that these play in regulating host responses to infections, we tested whether administration of cholinergic receptor agonists would rectify the macrophage phenotype and PCTR1 production. For this purpose we gave vagotomized mice carbachol, a muscarinic and nicotinic receptor agonist that is metabolically more resistant to further conversion than ACh. This upregulated the expression of macrophage lineage markers including COX-2, MHCII, CD11c, and Arg-1 on peritoneal macrophages when compared to vagotomized mice ( Figure 5A and Table  S5 ). Carbachol administration did not significantly regulate peritoneal CD335 + ILC3 numbers and PCTR1 in vagotomized mice ( Figures 5B and 5C ).
ILC3s are central in orchestrating the host immune response to bacterial infections (Mortha et al., 2014) , with factors produced by these cells being important in regulating both innate and adaptive immune responses. Given that ILC3 numbers were reduced in vagotomized mice, we next questioned whether loss of these cells from the peritoneum would reduce peritoneal PCTR1 concentrations and alter macrophage phenotypes. To address this, Rag1 À/À mice were given either an anti-CD90.2 antibody (see Experimental Procedures) that depleted peritoneal ILC3s by $75% (n = 6 mice; p < 0.05) or an isotype control. After 3 days, peritoneal lavages were obtained and assessed for peritoneal lipid mediator profiles and macrophage phenotype. Multivariate analysis of lipid mediator profiles obtained from these mice resulted in distinct lipid mediator clusters ( Figure 5D ). Assessment of the loading plot demonstrated an association between CD335 + ILC3s and PCTR1 ( Figure 5D ), with concentrations of this immunoresolvent being significantly reduced in mice given the anti-CD90.2 antibody when compared to mice given an isotype antibody (Table S6A ). In mice given the anti-CD90.2 antibody, we also found a shift in the peritoneal macrophage phenotype as demonstrated by multivariate analysis of phenotypic markers from these mice in comparison with macrophages from mice given an isotype control antibody ( Figure 5E and Table S6B ). We next tested whether these changes were associated with dysregulated host responses to infection. Mice administered the anti-CD90.2 antibody showed significant increases in peritoneal neutrophil recruitment at each time interval, with a $25% increase in J max and delay in the resolution interval from 18 hr to 25 hr compared to mice given an isotype control antibody (Figure 5F ). This reduction in peritoneal ILC3 numbers was also associated with a significant decrease in exudate leukocyte phagocytosis of E. coli, increased peritoneal bacterial load ( Figures 5G and 5H) , and increased inflammation-initiating eicosanoids PGD 2 , PGE 2 , PGF 2a , TXB 2 , and LTB 4 (n = 4 mice per group; p < 0.05). These results demonstrated that ILC3 depletion reduced peritoneal PCTR1 and altered the phenotype (A and B) After 16 hr, peritoneal lavages were collected and macrophage phenotype was determined using flow cytometry (A) and peritoneal LM profiles were determined using LM metabololipidomics (B).
(legend continued on next page) of peritoneal macrophages resulting in a dysregulated host response to infections.
Acetylcholine Upregulates the PCTR Biosynthetic Pathway in Human ILC3s that Promotes Resolution of Bacterial Infections
Given that lipid mediators, including PCTR1, regulate macrophage phenotype and function (Ramon et al., 2016; Serhan et al., 2015) , we next tested whether ILC3s controlled peritoneal macrophage responses via SPM production. We first sorted mouse ILC3s ($98% purity, Figure S1B ) and assessed the expression of 12/15-lipoxygenase (LOX), a key enzyme in pro-resolving mediator biosynthesis. Real-time qPCR (n = 3 mice) and flow cytometric analysis of mouse CD335 + ILC3s demonstrated that these cells expressed the murine homolog of this enzyme (Figure 6A ). In addition, real-time qPCR analysis of these sorted cells demonstrated that they also expressed the cholinergic receptors muscarinic (Chrm) 1, Chrm2, Chrm4, and Chrm5 (n = 3 mice). Incubation of CD335 + ILC3s with ACh, a key vagus-derived neurotransmitter (Vartiainen, 1934) , upregulate the levels of the PCTR1 pathway marker 17-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid (17-HDHA; Figure 6B ). We next tested whether these cells were responsible for regulating peritoneal macrophage PCTR1 production in vagotomized mice. Incubation of peritoneal macrophages with peritoneal CD335 + ILC3s (sorted as illustrated in Figure S2B ) resulted in increased PCTR1 production when compared to mice incubated with vehicle alone, and this action was reversed when ILC3s were incubated with a lipoxygenase inhibitor prior to incubation with peritoneal macrophages ( Figure 6C ). Given these actions, we investigate potential sites within the peritoneum where the crosstalk between cholinergic nerves, ILC3s, and macrophages could occur. Given the role of the greater omentum in leukocyte trafficking to the peritoneum (Fukatsu et al., 1996) and that the right vagus nerve fibers terminate in gastroepiploic plexus-the location of neural cell bodies that project axons in the gastroepiploic nerve that innervate this organ (Swanson, 2015) -we assessed whether these interactions may occur in the greater omentum. Using confocal microscopy, we identified RoRgt + CD3 À cells in close proximity to choline acetyltransferase-positive cells and F4/80 + cells ( Figure 6D ).
Since PCTR1 displays potent host protective actions, we next tested whether adoptive transfer of ILC3s would rectify the dysregulated host response in vagotomized mice. To this end, we sorted mouse ILC3s from enriched splenocytes populations following the gating strategy illustrated in Figure S5 . These cells were then adoptively transferred via i.p. injection to vagotomized animals 3 hr prior to E. coli inoculation and resolution indices were calculated. ILC3 administration led to a significant decreases in neutrophil recruitment, shortened the resolution interval from $26 hr to $11 hr, and reduced peritoneal bacterial loads when compared to vagotomized mice given only vehicle ( Figures 6E and 6F ). These protective actions were lost when ILC3s were incubated with a lipoxygenase inhibitor prior to administration to mice, thus supporting a role for ILC3-derived SPMs in regulating peritoneal resolution tone and host responses to infections.
To S6 ) and real-time qPCR (n = 4 donors), we found that human ILC3s expressed this SPM biosynthetic enzyme. Incubation of human ILC3s with ACh also significantly upregulated 17-HDHA levels (41.7 ± 7.4 versus 113 ± 13.1 pg/L 3 10 6 cells; ILC3 versus ILC3+Ach; p < 0.01). To further underpin the role of SPMs in mediating the protective actions of ILC3s and rule out the contribution of proteins in mediating these actions, we administered human ILC3s to mice 3 hr prior to infections. Human ILC3s were incubated with ACh and then administered to vagotomized mice, and this led to a significant reduction in neutrophil numbers in peritoneal exudates and shortening of the resolution interval by $10 hr, compared to vagotomized mice given only vehicle (Figure 6H ). These protective actions were lost when ILC3s were incubated with a lipoxygenase inhibitor prior to administration to vagotomized mice. Together these results demonstrate that ILC3s regulate peritoneal resolution tone and host responses to bacterial infections via SPMs, upregulating peritoneal macrophage PCTR1 levels and promoting the resolution of infectious inflammation.
DISCUSSION
Results from the present report detail a resolution circuit regulated by the vagal system that involves pro-resolving mediators, ILC3s, and resident peritoneal macrophages. Disruption of the vagal system led to an alteration in the cellular composition of resident innate immune cells in the peritoneum as well as a shift in the phenotype of tissue-resident macrophages. In addition, vagotomy resulted in an altered peritoneal lipid mediator profile with decrease in the tissue-protective and immunoresolvent PCTR1 and increased concentrations of inflammation-initiating eicosanoids. Vagotomy also delayed the resolution of E. coliinitiated bacterial infection. This delay in infection resolution was rescued by administration of either mouse or human ILC3s or PCTR1, which limited neutrophil infiltration to the site of infection, restored peritoneal macrophage responses, and enhanced the containment and clearance of bacteria. Together these findings indicate that ILC3s and PCTR1 are actively involved in regulating the tissue resolution capacity establishing (C) Peritoneal cells were collected, plated in 96-well plates (5 3 10 4 cells/well; DPBS; 2 hr; 37 C), then incubated with fluorescently labeled E. coli (2.5 3 10 6 CFU/ well; 37 C, PBS +/+ [pH 7.45], 40 min) and phagocytosis was assessed using a fluorescence microscopy. Results for (C) are mean ± SEM.
Results are representative of n = 5-6 mice per group from two distinct experiments.
(D-G) Mice were administered E. coli (1 3 10 6 CFU/mouse, i.p.). Exudates were collected at the indicated intervals and neutrophil count determined using flow cytometry and light microscopy (D). 12 hr exudate leukocyte E. coli phagocytosis was determined as CD11b + E. coli + cells (E) and 12 hr exudate bacterial loads (F) and 24 hr exudate macrophage efferocytosis (G) determined as F4/80 + Ly6G + cells.
Related to Tables S3 and S4 . (legend continued on next page) a resolution circuit that is under the control of the central nervous system. Regulation of peripheral host responses to injury or infection is now appreciated to be under the control of the nervous system, with the efferent vagal nerve involved in coordinating cellular recruitment and actions at the inflamed site (Pavlov and Tracey, 2015) . Disruption of the vagal system leads to a dysregulated host response and disease propagation after both sterile and infectious insults (Mirakaj et al., 2014; Pavlov and Tracey, 2015; Rosas-Ballina et al., 2011) . This regulation is in part mediated via the release of ACh by the vagus that regulates innate and adaptive immune cell responses during inflammation (Pavlov and Tracey, 2015) . Recently, we reported that the vagus also regulates resolution responses during sterile inflammation by modulating local levels of the neuronal guidance molecule netrin-1 as well as RvD1, RvD3, and PD1 (Mirakaj et al., 2014) . In the present study we found that the vagus also played a critical role in regulating the resolution tone of the peritoneum, whereby vagotomy led to a significant increase in resident peritoneal macrophage numbers, a shift in their phenotype to a pro-inflammatory phenotype, and a reduced ability to phagocytose bacteria. In these mice we also found a significant reduction in peritoneal ILC3 numbers and a shift in the peritoneal lipid mediator profile prior to challenge, with an increase in inflammation initiation eicosanoids and a reduction in PCTR1. In addition, vagotomy led to a disruption of resolution responses to pathogenic E. coli characterized by increased leukocyte recruitment, exudate inflammatory eicosanoids at the peak of inflammation (n = 5-6 mice per group; p < 0.05), a reduction in the ability of exudate leukocytes to phagocytose bacteria, and a delay in the resolution of infectious inflammation.
Tissue-resident cells provide the first line of defense against infections with innate cells, playing a critical role in initiating the inflammatory response (Kim and Luster, 2015) . In the peritoneum, resident macrophages are key players in orchestrating the initiation of the inflammatory response. Upon recognition of an inflammatory stimulus (e.g., bacteria), these cells produce a host of inflammatory signals including cytokines and lipid mediators that lead to vascular leakage and leukocyte recruitment (Hellmann et al., 2015) . In addition, these cells also actively participate in clearance of invading pathogens and alteration in their phenotype impairs their ability to clear bacteria and leads to a dysregulated inflammatory response in experimental systems (Dahdah et al., 2014) and humans (Ahmed et al., 2014) . In the present study we found that administration of PCTR1 to vagotomized mice 16 hr prior to challenge at a dose as low as 75 ng/mouse restored the macrophage phenotype as well as phagocytic function. In addition, this immunoresolvent also rectified the dysregulated peritoneal resolution responses in vagotomized mice, indicating a central role for PCTR1 in regulating the resolution tone in this tissue and in promoting the resolution of infectious inflammation.
It is now appreciated that tissue-resident ILC3s actively regulate macrophage responses in infections via the production of cytokines such as GM-CSF (Mortha et al., 2014) . In the present experiments, we found that murine and human ILC3s expressed the initiating enzyme in the production of PCTR1 and that incubation of ILC3s with ACh led to an increase in 17-HDHA, the biosynthetic pathway marker in the PCTR metabolome. In this context the actions of ACh on ILC3s may have been mediated by at least one of the cholinergic receptors Chrm1, Chrm2, Chrm4, and Chrm5 expressed by these cells. Depletion of ILC3s in Rag1 À/À mice led to a dysregulated peritoneal lipid mediator profile, a reduction in PCTR1 concentrations, an alteration of the peritoneal macrophage phenotype, and a delay in the resolution of infectious inflammation. Administration of human or mouse ILC3s prior to bacterial infection restored resolution responses in vagotomized mice, an action that was inhibited when these cells were pre-incubated with a lipoxygenase inhibitor. These results demonstrated that ILC3s carry the biosynthetic machinery necessary for the production of pro-resolving mediators. They also demonstrated that ACh, a central mediator in the vagal response, regulates the PCTR biosynthetic pathway in ILC3s that may in turn regulate resident peritoneal macrophage responses. Therefore, several lines of evidence were employed to determine the role of the right vagus in controlling peritoneal resolution tone and host responses to infections via ILC3 and PCTR1. They are as follows. (1 (H) 12 hr exudates were cultured on agar and bacterial loads were determined as colony-forming units (CFUs).
Results are mean ± SEM. n = 4 mice per group from two distinct experiments. Related to Table S6 . , 2% FBS). Incubations were quenched and PCTR1 levels determined using lipid mediator profiling. Results are mean ± SEM; n = 3 mice per group. *p < 0.05 versus Mf; #p < 0.05 is Mf plus ILC3. (D) Omenta were isolated from naive mice and stained for choline acetyltransferase (red), CD3 (green), F4/80 (cyan), and RoRgt (white) and staining was imaged using confocal microscopy (see Experimental Procedures for details). Magnification 340. Results are representative of n = 4 mice. (E) Mice were subjected to unilateral vagotomy surgery; after 7 days they were administered vehicle, CD335 + ILC3s (5 3 10 2 cells), DHA (1 mM) plus ACh (1 nM), or ILC3s with acetylcholine upregulated the PCTR1 pathway.
(9) ILC3s, macrophages, and cholinergic cells are found in close proximity in the greater omentum. (10) Incubation of peritoneal macrophage from vagotomized mice with ILC3s upregulated macrophage PCTR1 production, an action that was reversed when we incubated ILC3s with a lipoxygenase inhibitor.
(11) Addback of human and mouse ILC3s restored host responses to E. coli infections in vagotomized mice, protective actions that were lost when ILC3s were incubated with a lipoxygenase inhibitor.
In summation, the present results identify neural-regulated ILC3s pro-resolving mediator production that contributes to maintaining local homeostatic tissue tone and expedites resolution of bacterial infections. These results elucidate a mechanism for peripheral neuronal control in regulating ILC3 responses and PCTR1 production that orchestrate host responses during infections. Thus, these results indicate that impairment of the cholinergic system, as found in aging, for example, diminishes pro-resolving mediator production by resident leukocytes, leading to an altered tissue resolution tone and blunted resolution responses to infectious challenge. These findings may be useful in designing therapeutics for treating infectious inflammation that spares the immune response.
EXPERIMENTAL PROCEDURES
E. coli Peritonitis
All animal experiments were conducted in accordance with the Harvard Medical Area Standing Committee on Animals (protocol no. 02570) and UK Home Office regulations (Guidance on the Operation of Animals, Scientific Procedures Act, 1986). Mice (male FvB, 6-8 weeks old, Charles River, fed lab diet containing essential fatty acids as from supplier) were anesthetized and cervical vagotomy or sham surgery were performed 7 days before induction of peritonitis (Mirakaj et al., 2014) . In brief, mice were anesthetized and a ventral cervical midline incision was performed to expose the right cervical vagus trunk, which was ligated with a 4.0 silk suture and then divided. 1, 3, or 7 days later, peritoneal lavages and organ tissues were obtained. In select experiments 7 days after vagotomy, peritonitis was initiated by intraperitoneal injection of E. coli (serotype O6:K2:H1; 1 3 10 6 CFU/mouse). At designated time intervals, mice were harvested, blood was collected via cardiac puncture in heparin, and peritoneal exudates were collected by injecting in 4 mL of PBS intraperitoneally and $3 mL of PBS were recovered. The cellular composition in the exudates was determined using Turks solution and light microscopy and flow cytometry. For flow cytometry, exudate cells were incubated with anti-mouse CD16/CD32 (eBiosciences, 20 min, 4 C, in PBS containing 5% fetal calf serum-staining solution), followed by incubation with lineage-specific markers for 30 min (4 C, in staining solution). Cell counts for each population were then calculated by multiplying the total cell counts obtained using light microscopy and the percentage of each population as determined by flow cytometry and then normalized to 4 mL of PBS that was initially injected.
Flow Cytometry
Mouse cells were incubated with anti-mouse CD16/CD32 (eBiosciences, 20 min, 4 C, in PBS containing 5% fetal calf serum-staining solution), followed by incubation with lineage-specific markers for 30 min (4 C, in staining solution); all antibodies were purchased from BioLegend unless otherwise stated.
Multiparameter analysis was performed on FACS Canto II (BD), BD LSR Fortessa, and BD FACSAria II and analysis was conducted using FlowJo (Tree Star). For staining of intracellular components, we incubated cells with 
Lipid Mediator Profiling
Peritoneal lavages and infectious exudates were placed in 2 volumes of icecold methanol. Samples for LC-MS-MS-based metabololipidomics were extracted with solid-phase extraction columns (Colas et al., 2014) . In brief, prior (G) Human ILC3 expression of 15-lipoxygenase type I (15-LOX) was determined by flow cytometry. Results are representative of n = 4 donors. (H) Mice were subjected to unilateral vagotomy surgery, after 7 days they were administered vehicle, ILC3s (1 3 10 3 cells), DHA (1 mM) plus ACh (1 nM), or ILC3s
( ). An Agilent Eclipse Plus C18 column (100 3 4.6 mm 3 1.8 mm) was used with a gradient of methanol/water/acetic acid of 55:45:0.01 (vol:vol:vol) that was ramped to 85:15:0.01 over 10 min and then to 98:2:0.01 for the next 8 min. This was subsequently maintained at 98:2:0.01 for 2 min. The flow rate was maintained at 0.4 mL/min. To monitor and quantify the levels of lipid mediators, a multiple reaction monitoring (MRM) method was developed with signature ion fragments (m/z) for each molecule monitoring the parent ion (Q1) and a characteristic daughter ion (Q3). Identification was conducted using published criteria where a minimum of six diagnostic ions were employed (Colas et al., 2014) . Calibration curves were determined using a mixture of lipid mediators obtained via total organic synthesis. Linear calibration curve for each compound was obtained with r 2 values ranging from 0.98 to 0.99. Detection limit was $0.1 pg.
Quantification was carried out as in Colas et al. (2014) . For identification and quantification of PCTRs and cysteinyl leukotrienes, methanol fractions from solid-phase extractions (vide supra) were taken to the LC-MS-MS system operated as described (Dalli et al., 2015c) with minor modifications. A Shimadzu LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector paired with a QTrap 5500 (AB SCIEX) were used. A Poroshell 120 EC-C18 column (100 mm 3 4.6 mm 3 2.7 mm; Agilent) was kept in a column oven at 50 C (Therma Sphere; TS-130), and lipid mediators were eluted with a mobile phase consisting of methanol/water/acetic acid at 55:45:0.1 (vol:vol: vol) that was isocratic for 1 min, ramped to 70:30:0.1 over 5 min, then to 80:20:0.1 for 2 min, then isocratic 80:20:0.1 for the next 3 min, and ramped to 98:2:0.1 over 3 min. This was subsequently maintained at 98:2:0.1 for 3 min, and the flow rate was maintained at 0.6 mL/min. The QTrap 5500 was operated in positive ionization mode using scheduled multiple reaction monitoring (MRM) coupled with information-dependent acquisition and enhanced product ion scan. For complete chemical nomenclature for the SPM and other lipid mediators identified herein, see Colas et al. (2014) and Dalli et al. (2015c) .
Macrophage Incubations
Peritoneal macrophages from sham, vagotomized mice, and vagotomized mice given PCTR1 were collected in 4 mL of DPBS (without calcium and magnesium) and cells were counted and seeded (5 3 10 4 cells/well) in 96-well plates and allowed to adhere for 2 hr at 37 C. Non-adherent cells were washed and cells incubated with fluorescently labeled bacteria and phagocytosis was assessed using a Zeiss YFL (Carl Zeiss) and ImagePro Plus 7 software (Media Cybernetics) and SpectraMax M3 plate reader (Molecular Devices) and results analyzed using SoftMax Pro (Molecular Devices) (Chiang et al., 2012) .
In select experiments, macrophages (2 3 10 5 cells/well) were plated in 12-well plates and incubated for 2 hr at 37 C to allow for adhesion, then nonadherent cells were washed off and cells incubated with E. coli (1 3 10 7 CFU/well) for 6 hr at 37 C. Supernatants were then collected and centrifuged at 10,000 3 g for 10 min to remove any cellular debris and cytokine levels were assessed using a Proteome Profiler Mouse XL Cytokine Array Kit (R&D Systems) according to the manufacturer's instructions.
In separate experiments, macrophages from sham or vagotomized mice 1 and 7 days after vagotomy were plated in 6-well plates (1 3 10 6 cells/well, 45 min, 37 C, PBS +/+ ). Cell incubations were quenched using ice-cold methanol containing deuterium-labeled internal standards and lipid mediators identified and quantified as detailed above.
To investigate whether CD335 + ILC3s regulate macrophage responses, macrophages were isolated from vagotomized mice 2 days after vagotomy, and cells were plated in 6-well plates (1 3 10 6 cells/well, 45 min, 37 C,
PBS +/+
). Non-adherent cells were removed and cells incubated with CD335 + ILC3s (7.5 3 10 2 cells/well, 6 hr, 37 C, PBS +/+ , 2% FCS). Incubations were quenched using ice-cold methanol containing deuterium-labeled internal standards and PCTR1 was identified and quantified as detailed above.
Statistics
All results are expressed as means ± SEM. We assumed normality and equal distribution of variance between the different groups analyzed. The experiments were conducted and analyzed using a factorial design. Differences between groups were compared using Student's t test (2 groups), 1-way ANOVA, and 2-way ANOVA (multiple groups) followed by post hoc Bonferroni test. Investigators were not blinded to group allocation or outcome assessment. Sample sizes for each experiment were determined on the variability observed in preliminary experiments and prior experience with the experimental systems. The criterion for statistical significance was p < 0.05. PLS-DA analysis was conducted using SIMCA 13.0.3 software (Umetrics) as described in Colas et al. (2014) with mediators and macrophage lineage markers giving variable importance in projection scores greater than 1 taken as displaying significant correlation. This parameter estimates the importance of a variable in the partial least square projections with scores greater than 1 indicating that a specific variable is important in a given model.
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